Priority Date: 01.12.09 (US 20090265439P)

Treatment of IgE-mediated disease

  • Application ID: EP14194611
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicants

Research organisation logo small
Research Organisation
Research organisation logo small
Research Organisation

Attorney

no operation time available
Headquarter in Bristol and 7 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 193 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 01.12.2009 - Priority Date (US 20090265439P)
  • 15.04.2015 - Publication A1 (EP2860195)